Prognostic, predictive, and surrogate value of HER2 extracellular domain (ECD) for progression-free survival (PFS) in advanced breast cancer treated with lapatinib (lap): a meta-analysis

Chee Lee, Lucy Davies, Ian Marschner, Val Gebski, Sally Lord, Angelo Di Leo, Stephen R. D. Johnston, Charles E. Geyer, David A. Cameron, Michael F. Press, Catherine Elizabeth Ellis, Sherene Loi, John Simes, Paul De Souza

    Research output: Contribution to journalMeeting abstract

    Fingerprint

    Dive into the research topics of 'Prognostic, predictive, and surrogate value of HER2 extracellular domain (ECD) for progression-free survival (PFS) in advanced breast cancer treated with lapatinib (lap): a meta-analysis'. Together they form a unique fingerprint.

    Medicine & Life Sciences